Related Experiment Video
Updated: Sep 10, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Demystifying the nuances of the lipid patient: a guide for primary care providers
Merle Myerson1, Kyle Gillett2, James O'Hara2
1Myerson Medical and Health Writing and Consulting, Cooperstown, NY, USA.
Insights
Primary care providers can improve atherosclerotic cardiovascular disease (ASCVD) prevention by optimizing lipid management. This includes utilizing tools like the Predicting Risk of Cardiovascular Disease Events (PREVENT™) and nonstatin therapies to help patients reach low-density lipoprotein cholesterol (LDL-C) goals.
Area of Science:
- Cardiology
- Preventive Medicine
- Primary Care
Background:
- Atherosclerosis is a leading cause of death and disease in the US, driven by factors like elevated low-density lipoprotein cholesterol (LDL-C).
- Current lipid management in primary care often falls short, with many patients not achieving recommended LDL-C goals for atherosclerotic cardiovascular disease (ASCVD) prevention.
- Primary care physicians face challenges navigating various guidelines, risk tools, and therapies for effective lipid management.
Purpose of the Study:
- To provide primary care providers with essential knowledge regarding lipid management for ASCVD prevention.
- To review recent advancements in ASCVD prevention strategies, including risk assessment tools and nonstatin therapies.
- To empower primary care physicians in identifying at-risk patients and implementing effective lipid-lowering strategies.
Main Methods:
- Review of current literature and guidelines on lipid management and ASCVD prevention.
- Discussion of the role of primary care in lipid screening and patient management.
- Introduction of the Predicting Risk of Cardiovascular Disease Events (PREVENT™) tool for risk stratification.
- Overview of nonstatin lipid-lowering therapy options and their application.
Main Results:
- Inadequate achievement of LDL-C goals remains a significant issue in clinical practice.
- Effective lipid management requires understanding patient-specific risk factors and available therapeutic options.
- Newer tools and therapies offer improved approaches to ASCVD risk reduction.
Conclusions:
- Primary care providers play a crucial role in enhancing ASCVD prevention through proactive lipid management.
- Utilizing updated risk assessment tools and considering nonstatin therapies can improve patient outcomes.
- Addressing challenges in lipid management is essential for reducing ASCVD morbidity and mortality.
Abstract:
Atherosclerosis, a major cause of mortality and morbidity in the United States (US), is driven by complex factors, including the cumulative burden of low-density lipoprotein cholesterol (LDL-C) and other atherogenic lipids and lipoproteins. Lipid management in US primary care aims to prevent atherosclerotic cardiovascular disease (ASCVD) events through screening and LDL-C lowering to risk-based goals. However, lipid screening and ASCVD treatment is often inadequate, with few patients meeting LDL-C goals in clinical practice. Primary care providers have a vital role in identifying patients most at risk of ASCVD to prevent ASCVD events and improve patient outcomes. There are multiple different management guidelines, risk stratification tools, tests, and management strategies available to primary care physicians. Understanding the nuances of the lipid patient and how to employ these tools can be challenging. Here, we aim to summarize what primary care providers need to know about the lipid patient and why. We review recent updates in ASCVD prevention, including the Predicting Risk of Cardiovascular Disease Events (PREVENT™) tool and nonstatin lipid-lowering therapy management approaches.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
What are Lipids?
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

